CDC Must Still Approve
Washington, D.C.-(ENEWSPF)- The U.S. Food and Drug Administration took action approving and authorizing for emergency use updated COVID-19 vaccines. Vaccine researchers developed these to more closely target currently circulating variants. They provide better protection against serious consequences of COVID-19, including hospitalization and death. Today’s actions relate to updated mRNA vaccines for 2023-2024 manufactured by ModernaTX Inc. and Pfizer Inc. Consistent with the totality of the evidence and input from the…
